Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Carl Zeiss Meditec-dublin Coce

Clinical trials sponsored by Carl Zeiss Meditec-dublin Coce, explained in plain language.

Now part of Carl Zeiss Meditec AG AFX XETRA

Subsidiary of Carl Zeiss Meditec, focusing on medical technology and ophthalmic devices.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

AI eye scanner could catch retina disease earlier

Diagnosis Recruiting now

This study evaluates PathFinder 1.0, a software that analyzes OCT images of the retina to detect macular abnormalities such as epiretinal membrane, dry age-related macular degeneration, and other retinal conditions. About 400 adults with and without macular issues will undergo st…

Phase: NA • Sponsor: Carl Zeiss Meditec-Dublin CoCe • Aim: Diagnosis

Last updated Jul 04, 2026 00:00 UTC